Dysis Medical Limited

Dysis Medical Ltd, based in London, UK, is a small holding company with an active status, having operated for 23 years. Employing 15 individuals, the company holds assets totaling £2,874,693, though its registered address is a virtual one, shared by thirteen other companies. Two directors and one owner guide the business, which regularly imports and exports optical and medical tools and devices – 38 months of imports and 70 months of exports recorded.

The company’s primary focus is computeraided colposcopy, as evidenced by its website. Dysis Medical provides equipment and services for cervical cancer screening, targeting healthcare professionals and patients alike. The site details the benefits of its technology, including improved detection of lesions and enhanced patient understanding. It even features testimonials from satisfied customers, highlighting the system’s accuracy and ease of use. The company’s website also details a recent acquisition by Apgar Danmark AS, which took over global rights for the company’s equipment.

Financially, Dysis Medical Ltd’s report reveals some interesting trends. While the company’s assets remain substantial at £2,874,693, there’s a noticeable shift in its financial landscape. Bank borrowings increased significantly, suggesting a need for external funding. Although the company’s size—meeting two of three criteria for a small company—allows for agility, the increased reliance on borrowing raises questions. The report also notes deferred tax recognition, indicating a strategy for managing tax liabilities. With no auditor mentioned, the financial data relies on unaudited statements.

Overall, Dysis Medical Ltd appears to be a specialized player in the medical technology sector, navigating the challenges of growth and funding while maintaining its focus on innovation and patient care.

Registered in England/Wales under the registration number 04446534, with a registered address at EC2V 6AA, England, London, Octagon Point, 5 Cheapside.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.